Phage display is a versatile and powerful method for generating antibodies with high specificity, affinity and functionality. Its advantages make it a valuable tool for antibody discovery and development in a wide range of applications, including therapeutics and research.

In essence, phage display is a technique that allows the selection of antibodies, or antibody fragments, with a specific binding affinity for a target antigen. Bacteriophages (viruses that infect bacteria) are engineered to display a library of antibody fragments on their surface then mixed with an immobilized target antigen. The phages that bind to the antigen are isolated and amplified. The process is repeated multiple times to isolate the phage that displays the highest binding affinity to the target antigen. Once the phage with the desired antibody fragment is identified, the DNA sequence encoding the fragment can be extracted and used to produce large quantities. The antibody fragments are derived from a library of light and heavy chains with minor or major alterations that are hypothesized to impact binding efficiency and/or specificity.

How Phage Display Works

The seven-step phage display process to produce and identify antibodies that can specifically bind to a target antigen:

• Create a library of antibodies or antibody fragments: Bacteriophage libraries are engineered to display a vast number of antibody fragments on their surface. The antibody fragments are typically derived from immunized animals or human donors. A combinatorial library of antibody fragments can be created by synthesizing or amplifying diverse antibody sequences using techniques such as PCR or synthetic DNA assembly. The library can be designed to include specific regions of diversity, such as the complementarity-determining regions (CDRs), which are responsible for antibody-antigen interactions.
• Incubation with target antigen: The library of phages is then incubated with the target antigen, which can be a protein, peptide, or small molecule. This step is the start of the panning process which can last multiple rounds.
• Selection and isolation: Phages that bind to the target antigen are selectively isolated. This step can be achieved using various techniques, such as magnetic beads or affinity chromatography after washing away non-binders.
• Elution of phages: Once the phages are isolated, they can be eluted from the target antigen and collected for further rounds of selection. Prior to further rounds of selection, selected phages can be amplified through a reinfection step with the addition of a helper phage, if needed.
• Screening: Phages that bind to the target antigen are further screened to identify those with the highest binding affinity. This can include an enzyme-linked immunosorbent assay (ELISA), Western blot, surface plasmon resonance, or immunofluorescence assays.
• DNA sequencing: The DNA sequence encoding the antibody fragment that binds to the target antigen is then extracted, sequenced and amplified.
• Antibody production: The DNA sequence is then cloned into an expression vector and used to produce the full-length antibody for therapeutic or research purposes.

Featured Product

Applications of Phage Display

Phage display offers diverse applications for antibody discovery and development. With the advancements in phage display technology, it is likely to play an even more significant role in the production of antibodies in the future. Applications include:

• High-throughput screening: The use of automation and robotics in phage display technology enables screening large libraries of antibodies against multiple targets in a shorter period, leading to the identification of novel antibody candidates.
• Multi specific antibodies: Phage display can be used to produce multi specific antibodies that can bind to two or more different targets simultaneously, leading to more effective therapeutic interventions.
• Antibody engineering: With advanced computational tools and synthetic biology techniques, phage display can be used to engineer antibodies with specific properties, such as increased stability, reduced immunogenicity and improved pharmacokinetics.

Advantages of Phage Display for Generating Antibodies

Phage display is a powerful and widely used technique for generating antibodies that offers several advantages over other methods. One of the main benefits of phage display is its ability to generate large libraries of diverse antibodies relatively quickly. This is because the technique involves inserting genes encoding antibody fragments into bacteriophages, which are then used to create a library of phages displaying various antibody fragments. This approach allows simultaneous screening of millions of potential antibodies, providing a high-throughput method for antibody generation. In contrast, traditional antibody generation techniques, such ashybridoma technology, typically involve the fusion of B cells with myeloma cells to create hybridoma cell lines that produce monoclonal antibodies. While effective, this method can be time-consuming and resource-intensive, as it requires screening individual cell lines for the desired antibody.

Another advantage of phage display is its ability to generate antibodies against difficult or complex targets. Because the technique relies on screening large antibody libraries, it can identify antibodies that bind to targets that may not be accessible by other methods. For example, phage display has been used to generate antibodies against membrane proteins, which are notoriously difficult to work with due to their hydrophobic nature and limited solubility. Additionally, phage display can be used to generate antibodies against non-protein targets, such as small molecules and carbohydrates.

Finally, phage display offers a significant advantage over traditional antibody generation methods that rely on animal immunization or cell culture and provide a cost-effective means of producing antibodies using bacteriophage and E.coli.

recent-articles